Skip to main content
. 2020 May 1;21(9):3213. doi: 10.3390/ijms21093213

Figure 2.

Figure 2

The result of anti-tumor effect of syn-miR-143 on breast cancer xenograft tumor in vivo. Time course of tumor size in MB-231 cell-xenografted nude mice treated with control RNA or syn-miR-143. Arrow represents a treatment with control RNA (1.5 mg/kg/administration) or syn-miR-143 (1.5 mg/kg/administration) given every 3 days. Syn-miR-143, synthetic miR-143.